The optimal treatment of patients with localized prostate cancer: the debate rages on
23 Comments
/
The widely anticipated results of the ProtecT study have now been published. Unfortunately, the results do little to advance our understanding as to whether surgery or radiation provides better outcomes.
In summary
The study followed oncologic and functional outcomes of 545 patients randomized to active monitoring (surveillance), 553 to radical prostatectomy, and 545 to radiotherapy. With a median follow-up of 10 years, the authors report no significant differences in prostate cancer…
Asia-Pacific Prostate Cancer Conference 2016 Highlights
After briefly venturing to tropical Cairns in 2015, the Asia-Pacific Prostate Cancer Conference returned to its traditional home in Melbourne for its 17th edition in 2016 (#APCC16). The meeting has previously featured the who’s who of prostate cancer and this year was no different with an all-star multidisciplinary faculty consisting of 18 international members in addition to our local experts. The meeting was well attended by over the 750 delegates from all parts of the globe and remains one of…
September’s BJUI – About the Cover
The lead author of this issue's Article of the Month is based in Helsinki, the cover images shows two of the statues that flank Helsinki Central Station, which was selected by the BBC as one of World's ten most beautiful railway stations.
©istock.com/PeJo29
Click here for this issue’s Table of Contents
Randomised Controlled Trials in Robotic Surgery
It has been nearly 15 years since one of the first ever randomised controlled trials (RCT) in robotic surgery was conducted in 2002. The STAR-TRAK compared telerobotic percutaneous nephrolithotomy (PCNL) to standard PCNL and showed that the robot was slower but more accurate than the human hand [1].
In the 24 h since the much anticipated RCT of open vs robot-assisted radical prostatectomy was published in The Lancet [2], our BJUI blog from @declangmurphy was viewed >2500 times,…
The impact factor may be flawed but important
It has been a nice summer for the BJUI. Our impact factor has gone up to 4.387, the highest ever in the history of the Journal and we made the Altmetrics Top 50 for the first time ever with a score of 1166, Nature being the numero uno. I wanted to thank our editorial team, readers, authors and reviewers for their dedication and commitment, which made this possible.
The question is how did we do this? For a journal without official society guidelines, it was not easy. So we had to…
It’s not about the machine, stupid
Robotic surgery trial exposes limitations of randomised study design
Here it is, the highly anticipated randomised controlled trial of open versus robotic radical prostatectomy published today in The Lancet. Congratulations to the team at Royal Brisbane Hospital for completing this landmark study.
The early headlines around the world include everything from this one in the Australian Financial Review:
- to this from The Telegraph in London
As ever,…
August’s BJUI – About the Cover
This issue, the Article Of the Month comes from Dresden, the capital city of the Free State of Saxony in Germany.
The cover shows the Dresden skyline along the River Elbe, including the Frauenkirche.
©istock.com/Jule_Berlin
Click here for this issue’s Table of Contents
Highlights from BAUS 2016
In the week following Britain’s exit from Europe after the BREXIT referendum, BAUS 2016 got underway in Liverpool’s BT convention Centre. This was the 72nd meeting of the British Association of Urological Surgeons and it was well attended with 1120 delegates (50% Consultant Member Urologists, 30% Trainees, 10% Non member Urologists/Other, 10% Nurses, HCP’S, Scientists).
Monday saw a cautionary session on medicolegal aspects in Andrology, focusing on lawsuits over the last year. Mr…
Urology in Zomba, Malawi. Reflecting on surgical care in a Resource-Limited country
At the recent AUA meeting in San Diego as at all of our major meetings, a tremendous amount of data was presented and technology displayed to advance our specialty. Walking through exhibit hall one sees an expensive bauble at every turn. The advancement of urology over the last 50 years has been remarkable. We have a lot to be proud of. I think we have the most interesting, exciting specially in all of medicine. Urologist are generally technophiles and have always loved to push surgical…
The PROMIS of MRI
The prostate cancer pathway is controversial and views are often polarized. For a researcher, this is the perfect melting pot for innovation and practice-changing studies. It is clear that we need to reduce the harms of treatment, not only by treating very few low-risk cancers but also by innovations in surgery. It is pleasing to see Grasso et al. [1] systematic review of surgical innovation that may potentially lead to improvements in urinary incontinence after radical prostatectomy. This was a…